{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-eu-ctr-ctis-submissions-and-lifecycle-management”
},
“headline”: “SOP for EU CTR/CTIS Submissions and Lifecycle Management”,
“description”: “This SOP describes procedures for managing clinical trial submissions and lifecycle activities under the EU Clinical Trials Regulation (CTR) and the Clinical Trials Information System (CTIS). It covers sponsor and CRO responsibilities, substantial modifications, results submission, and compliance with EMA transparency requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 21/12/2025
Standard Operating Procedure for EU CTR/CTIS Submissions and Lifecycle Management
| SOP No. | CR/OPS/136/2025 |
| Supersedes | NA |
| Page No. | 1 of 77 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to outline procedures for submission and lifecycle management of clinical
Scope
This SOP applies to sponsors, CROs, regulatory affairs personnel, and QA staff involved in EU CTR submissions. It covers initial trial application, substantial modifications, ongoing trial updates, results posting, transparency compliance, and inspection readiness under EMA oversight.
Responsibilities
- Sponsor: Ensures timely preparation and submission of CTR applications and lifecycle documents.
- CRO: Supports regulatory submission preparation, translation management, and document upload in CTIS.
- Regulatory Affairs: Reviews and submits CTIS entries, manages communications with NCAs and Ethics Committees.
- QA: Audits submission processes, verifies document integrity, and ensures readiness for EMA inspections.
- Investigator: Provides site-level documentation and ensures consistency with CTR requirements.
Accountability
The Sponsor’s Regulatory Affairs Lead is accountable for all EU CTR/CTIS submissions and lifecycle management activities. CROs share accountability for delegated responsibilities.
Procedure
1. Initial Clinical Trial Application
1.1 Prepare CTA dossier according to EU CTR Annex I.
1.2 Upload documents (protocol, IMPD, IB, informed consent, etc.) in CTIS.
1.3 Record submission in EU CTR Application Log (Annexure-1).
2. Validation and Assessment
2.1 Monitor validation requests from Member States.
2.2 Respond to requests within required timelines (10/12 days).
2.3 Document in Validation Response Log (Annexure-2).
3. Substantial Modifications
3.1 Identify modifications requiring resubmission (e.g., protocol amendments, safety changes).
3.2 Submit through CTIS with justification.
3.3 Record in Modification Log (Annexure-3).
4. Ongoing Trial Updates
4.1 Update recruitment status, investigator sites, and safety reports in CTIS.
4.2 Document in Ongoing Update Log (Annexure-4).
5. Results Posting
5.1 Submit summary results within 12 months of trial completion.
5.2 Pediatric trials must be posted within 6 months.
5.3 Record in Results Submission Log (Annexure-5).
6. Transparency and Public Disclosure
6.1 Ensure consistency with EMA transparency rules.
6.2 Flag documents requiring confidentiality protection.
6.3 Record in Transparency Log (Annexure-6).
7. Archiving and Inspection Readiness
7.1 Maintain inspection-ready CTIS records.
7.2 Archive all CTR/CTIS documents in TMF.
7.3 Document in Archiving Log (Annexure-7).
Abbreviations
- SOP: Standard Operating Procedure
- EU CTR: European Union Clinical Trials Regulation
- CTIS: Clinical Trials Information System
- CTA: Clinical Trial Application
- EMA: European Medicines Agency
- CRO: Contract Research Organization
- QA: Quality Assurance
- TMF: Trial Master File
Documents
- EU CTR Application Log (Annexure-1)
- Validation Response Log (Annexure-2)
- Modification Log (Annexure-3)
- Ongoing Update Log (Annexure-4)
- Results Submission Log (Annexure-5)
- Transparency Log (Annexure-6)
- Archiving Log (Annexure-7)
References
- EMA – Clinical Trials Information System (CTIS)
- EU Clinical Trials Regulation (EU CTR 536/2014)
- ICH GCP – International Standards
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, Regulatory Affairs Specialist |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Operations |
Annexures
Annexure-1: EU CTR Application Log
| Date | Protocol ID | Submission Status | Submitted By | Status |
|---|---|---|---|---|
| 01/09/2025 | CTR-2025-01 | Submitted | Reg Affairs | Filed |
Annexure-2: Validation Response Log
| Date | Protocol ID | Validation Query | Response Submitted | Status |
|---|---|---|---|---|
| 05/09/2025 | CTR-2025-01 | Investigator CV Missing | Yes | Resolved |
Annexure-3: Modification Log
| Date | Protocol ID | Modification | Submitted By | Status |
|---|---|---|---|---|
| 10/09/2025 | CTR-2025-01 | Protocol Amendment 1 | Reg Affairs | Approved |
Annexure-4: Ongoing Update Log
| Date | Protocol ID | Update | Submitted By | Status |
|---|---|---|---|---|
| 15/09/2025 | CTR-2025-01 | Recruitment Status Changed | CRO | Filed |
Annexure-5: Results Submission Log
| Date | Protocol ID | Results Submitted | Submitted By | Status |
|---|---|---|---|---|
| 20/09/2025 | CTR-2025-01 | Yes | Data Manager | Filed |
Annexure-6: Transparency Log
| Date | Protocol ID | Confidential Document | Flagged | Status |
|---|---|---|---|---|
| 22/09/2025 | CTR-2025-01 | Pharmacovigilance Plan | Yes | Restricted |
Annexure-7: Archiving Log
| Date | Protocol ID | Archived By | Location | Status |
|---|---|---|---|---|
| 30/09/2025 | CTR-2025-01 | QA Officer | TMF | Completed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Operations |
For more SOPs visit: Pharma SOP